4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000921895-20-003278
BVF PARTNERS L P/IL acquired 1,289,628 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-22 | Conversion : show line 1 in the form | +15,166 | 117,565 | D |
| 2020-12-22 | Conversion : show line 2 in the form | +654,215 | 771,780 | D |
| 2020-12-22 | Conversion : show line 3 in the form | +11,278 | 89,214 | D |
| 2020-12-22 | Conversion : show line 4 in the form | +509,410 | 598,624 | D |
| 2020-12-22 | Conversion : show line 5 in the form | +1,944 | 15,537 | D |
| 2020-12-22 | Conversion : show line 6 in the form | +97,615 | 113,152 | D |
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-22 | Conversion : show line 7 in the form Series X Convertible Preferred | −273 | 0 | D |
| 2020-12-22 | Conversion : show line 8 in the form Series X Convertible Preferred | −203 | 0 | D |
| 2020-12-22 | Conversion : show line 9 in the form Series X Convertible Preferred | −35 | 0 | D |
| 2020-12-22 | Conversion : show line 10 in the form Series X1 Convertible Preferred Stock | −11,776 | 52,145 | D |
| 2020-12-22 | Conversion : show line 11 in the form Series X1 Convertible Preferred Stock | −9,169 | 39,693 | D |
| 2020-12-22 | Conversion : show line 12 in the form Series X1 Convertible Preferred Stock | −1,757 | 6,758 | D |
Loading xslF345X03/form407422010_12282020.xml…